HER2 Signaling in Breast Cancer Treatment (Q167950): Difference between revisions

Latest revision as of 21:13, 12 September 2024

HER2 signaling in breast cancer treatment, focusing on targeted therapies like trastuzumab.

Language	Label	Description	Also known as
English	HER2 Signaling in Breast Cancer Treatment	HER2 signaling in breast cancer treatment, focusing on targeted therapies like trastuzumab.

0 references

0 references

@@ aliases / en / 0 / aliases / en / 0 @@
-HER2
@@ aliases / en / 1 / aliases / en / 1 @@
-breast cancer
@@ aliases / en / 2 / aliases / en / 2 @@
-trastuzumab
@@ aliases / en / 3 / aliases / en / 3 @@
-EGFR
@@ aliases / en / 4 / aliases / en / 4 @@
-monoclonal antibody
@@ aliases / en / 5 / aliases / en / 5 @@
-chemotherapy
@@ aliases / en / 6 / aliases / en / 6 @@
-metastatic
@@ aliases / en / 7 / aliases / en / 7 @@
-receptor tyrosine kinases
@@ aliases / en / 8 / aliases / en / 8 @@
-neuregulin 1
@@ aliases / en / 9 / aliases / en / 9 @@
-ADAM metalloproteinases
@@ description / en / description / en @@
-This cluster of papers focuses on the use of HER2-targeted therapies, such as trastuzumab and pertuzumab, in the treatment of HER2-positive breast cancer
+HER2 signaling in breast cancer treatment, focusing on targeted therapies like trastuzumab.
@@ Property / same as @@
-https://openalex.org/T10755
@@ Property / same as: https://openalex.org/T10755 / rank @@
-Normal rank
@@ Property / OpenAlex ID @@
+T10755
@@ Property / OpenAlex ID: T10755 / rank @@
+Normal rank